Analysis of the tremor in juvenile myoclonic epilepsy

Zeynep Aydin-Özemir1, Zeliha Matur2, Betul Baykan3

  • 1Istanbul University, Istanbul Faculty of Medicine, Departments of Neurology and Clinical Neurophysiology, Istanbul, Turkey; Umraniye Training And Research Hospital, Department of Neurology, Istanbul, Turkey.

Epilepsy Research
|November 12, 2016
PubMed
Abstract

Insights

Juvenile myoclonic epilepsy (JME) patients with tremor show distinct characteristics, including irregular myoclonic jerks, differentiating them from essential tremor (ET). These findings aid in classifying JME patients for research.

Area of Science:

  • Neurology
  • Epileptology
  • Movement Disorders

Background:

  • Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome.
  • Tremor can be a presenting symptom in JME, sometimes unrelated to medication.
  • Distinguishing JME-associated tremor from other tremor disorders like essential tremor (ET) is crucial for accurate diagnosis and research.

Purpose of the Study:

  • To investigate tremor in JME patients not associated with valproate (VPA) treatment.
  • To differentiate between JME patients with and without tremor.
  • To compare JME patients with tremor to essential tremor (ET) patients and healthy subjects (HS) to exclude comorbidity.

Main Methods:

  • Inclusion of four groups: JME with tremor (15), JME without tremor (14), ET (14), and HS (14).
  • Accelerometric analysis to assess tremor regularity, frequency, and amplitude, and superimposed myoclonia.
  • Recording of cortical somatosensory evoked potentials (SEPs) via median nerve stimulation.
  • Statistical comparison of clinical and neurophysiological features across groups.

Main Results:

  • JME patients with tremor exhibited superimposed irregular, low-amplitude myoclonic jerks.
  • ET patients showed significantly higher postural tremor amplitude than JME patients with tremor.
  • JME patients with tremor had higher N20-P25 and P25-N35 SEP amplitudes compared to other groups.

Conclusions:

  • Tremulous hand movements in JME resemble ET but are characterized by lower amplitude and accompanying myoclonic jerks.
  • Identifying tremor in JME is important for creating more homogeneous patient cohorts for genetic and pathophysiological studies.
  • These findings highlight distinct neurophysiological characteristics of tremor in JME.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K